The business program of the X All-Russian GMP Conference with international participation covers a wide range of issues related to ensuring quality in the production of medicinal products, regulatory affairs, interagency and international cooperation in the pharmaceutical industry.

The quarterly review provides information on the inspection of manufacturers of veterinary medicines for compliance with the requirements of the GMP which is carried out by specialists of the Inspection Body of the FSBI "VGNKI".

GEROPHARM and OOO “R-Pharm” (member of R-Pharm Group of Companies) have announced a strategic partnership to localise the production of medicines for the treatment of socially significant diseases in Azerbaijan.

In the first quarter of 2025, the Zelenograd production site of Binnopharm Group increased its output of medicinal products for export by almost three times compared to the same period in 2024.

Vamotinib is about to be registered and put into civil circulation by Pharmasyntez, a Russian pharmaceutical company that aims to provide Russian patients with access to new and innovative medications.

The quarterly review provides information on the inspection of manufacturers of veterinary medicines for compliance with the requirements of the Good Manufacturing Practice (GMP)...